Business
Trademark Approval for ECOVAXXIN® family in the EU
Trademark Approval for ECOVAXXIN® family in the EU.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n06 February 2024\n \n \n \n \n \nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nTrademark Approval for ECOVAXXIN® family in the EU\n ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, is pleased to announce that the ECOVAXXIN® trademark has been approved by the European Union (\"EU\").\nIn addition to this EU trademark ECOVAXXIN® has also been registered in the USA and in the UK, giving extensive protection in key markets for animal health products.\nThe registration for ECOVAXXIN® provides trademark branding for a family of vaccine products. ECOVAXXIN® is a master trademark and will protect all ECO's forthcoming vaccine products. Starting in 2025, the Company plans to market its vaccine products in multiple jurisdictions, with multiple planned launches over the next ten year period.\nThe first two planned products to carry the trademark will be the Company's poultry mycoplasma vaccines, specifically ECOVAXXIN® MS, a vaccine against Mycoplasma Synoviae, and ECOVAXXIN® MG, a vaccine against Mycoplasma Gallisepticum.\nThe trademark approval supports ECO's strategy of accelerating growth through the Company's research and development pipeline. The addition of new vaccines is expected to significantly support sales and profit growth over the next ten years.\nDavid Hallas, Chief Executive Officer of ECO Animal Health Group plc, commented: \"This trademark approval, complemented by registrations in the USA and the UK, provides broad protection for the ECOVAXXIN® family, fortifying our commitment to advancing growth through innovative vaccine products and supporting our strategic focus on R&D-driven expansion at ECO Animal Health Group plc.\"\n-Ends-\nFor further information please contact:\n \n\n\n\n\n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\n...